We report here that tumor angiogenesis-mediated endothelial cell (EC) anergy can be overcome by inhibitors of angiogenesis. We found previously that tumor growth, known to be dependent on angiogenesis, results in down-regulation of endothelial adhesion molecules and tumor EC anergy to inflammatory s
Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline
β Scribed by Rajiv P. Gude; Mercedes M. Binda; Alejandra L. Boquete; Daniel R. Bonfil
- Publisher
- Springer-Verlag
- Year
- 2001
- Tongue
- English
- Weight
- 184 KB
- Volume
- 127
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Hyperhomocysteinemia (HHcy) has been shown to induce endothelial dysfunction, an early event in the progression of atherosclerosis. However, the underlying mechanism of endothelial cell injury in HHcy has not been clearly elucidated. In this study, we examined the effect of homocysteine
## Abstract The effect of irradiation of tumors on their ability to induce vascular responses (angiogenesis) was studied. Rat Walker carcinoβsarcoma 256, rabbit V2 carcinoma, mouse (C57Bl) melanoma and mouse (129) teratoma (OTT 6050, 100K) were irradiated with up to 5000R, then grafted either to th
## Abstract Targeting of proliferating endothelial cells may allow a new therapeutic strategy against malignant tumors. Endothelial cells are easily accessible through the blood stream and genetically stable, reducing the possibility of acquiring drug resistance. There are numerous candidates for a
S-nitroso-N-acetyl-D,L-acetylpenicillamine (SNAP), a chemical donor of NO, inhibited serum-and basic fibroblast growth factor (bFCF)-stimulated cultured endothelial cell (EC) proliferation in a dose-dependent manner. The inhibitory effect of NO was reversible after washoff of SNAP-containing media.